Dr. Tiacci on Standard of Care in Hairy Cell Leukemia Treatment
October 25th 2019Enrico Tiacci, MD, discusses the current treatment options for patients with hairy cell leukemia. Currently, the standard of care for these patients are purine nucleoside analogs, including pentostatin and cladribine.
Read More